Nuvalent, Inc.
NUVL
DELAYED 1 MONTH
11 insider filings · Latest: Jun 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 11 8:30 PM | Darlene NociChief Development Officer | Sale | 20,000 | $122.81 | $2.5M | 58,117(D) | View → |
| Jun 8, 2026 | Jun 10 8:30 PM | James Richard PorterDirector, President and CEO | Sale | 30,000 | $88.53 | $2.7M | 324,879(D) | View → |
| Jun 1, 2026 | Jun 3 8:30 PM | Alexandra BalcomChief Financial Officer | Sale | 11,430 | $98.69 | $1.1M | 85,533(D) | View → |
| May 28, 2026 | Jun 1 8:31 PM | Darlene NociChief Development Officer | Sale | 5,500 | $107.80 | $592.9K | 58,117(D) | View → |
| May 28, 2026 | Jun 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Sale | 5,500 | $107.84 | $593.1K | 59,634(D) | View → |
| May 4, 2026 | May 6 8:30 PM | James Richard PorterDirector, President and CEO | Sale | 30,000 | $101.69 | $3.1M | 324,879(D) | View → |
| May 1, 2026 | May 5 8:30 PM | Alexandra BalcomChief Financial Officer | Sale | 11,430 | $99.00 | $1.1M | 85,533(D) | View → |
| Apr 30, 2026 | May 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Sale | 5,500 | $99.22 | $545.7K | 59,634(D) | View → |
| Apr 29, 2026 | May 1 8:30 PM | Darlene NociChief Development Officer | Sale | 5,500 | $99.55 | $547.5K | 58,117(D) | View → |
| Mar 13, 2026 | Mar 16 8:31 PM | Henry E. PelishChief Scientific Officer | Sale | 5,104 | $98.98 | $505.2K | 65,604(D) | View → |
| Mar 12, 2026 | Mar 16 8:31 PM | Henry E. PelishChief Scientific Officer | Sale | 30,000 | $97.92 | $2.9M | 70,708(D) | View → |
| Mar 6, 2026 | Mar 10 8:30 PM | James Richard PorterDirector, President and CEO | Sale | 30,000 | $98.99 | $3.0M | 324,879(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 11 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 20,000 | $18.93 | 24,258(D) | View → |
| Jun 8, 2026 | Jun 10 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $18.93 | 148,686(D) | View → |
| Jun 1, 2026 | Jun 3 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $6.89 | 13,400(D) | View → |
| May 28, 2026 | Jun 1 8:31 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 86,829(D) | View → |
| May 28, 2026 | Jun 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 72,608(D) | View → |
| May 4, 2026 | May 6 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $18.93 | 178,686(D) | View → |
| May 1, 2026 | May 5 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $6.89 | 24,830(D) | View → |
| Apr 30, 2026 | May 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 78,108(D) | View → |
| Apr 29, 2026 | May 1 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 92,329(D) | View → |
| Mar 12, 2026 | Mar 16 8:31 PM | Henry E. PelishChief Scientific Officer | Option Exercise | 17,320 | $72.35 | 21,073(D) | View → |
| Mar 6, 2026 | Mar 10 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $27.85 | 147,780(D) | View → |